# BioScreen CI — Continuous Independent Assurance for Nucleic-Acid Synthesis Screening (idea-397)

**Score:** 94.4/100  |  **Category:** Biosecurity & Synthetic Biology Safeguards  |  **Rank:** 🥉 Round #12 3rd Place (3rd / 12)

## Executive Summary

BioScreen CI delivers continuous, independent operational assurance for gene synthesis biosecurity screening systems. Following U.S. federal mandates (May 2025/2026 ASPR framework) requiring federally funded research procurement to use verified screening providers, BioScreen CI acts as an independent SOC 2 / penetration-testing harness for nucleic-acid synthesis providers.

## Regulatory Context & Capability Frontier

The White House and U.S. HHS/ASPR established updated screening requirements for sequence and customer verification. Meanwhile, open screening tools (IBBIS) and generative biology advances (e.g., April 2026 *Science* paper on generative bacteriophage design) have accelerated both provider adoption and potential evasion vectors.

BioScreen CI does not build another sequence classifier. It tests whether the synthesis provider's **entire operational pipeline** remains functional against evolving threat profiles and software regressions.

## Continuous Assurance Architecture

```
Synthesis Provider Pipeline
   │
   ├─ Customer Identity Verification
   ├─ Sequence Classifier Engine (IBBIS / SecureDNA)
   ├─ Human Escalation Workflow
   ├─ Order Routing & Benchtop Synthesizer API
   │
   ▼
BIOSCREEN CI AIR-GAPPED ASSURANCE SUITE
   │
   ├─ Controlled Challenge Classes (A–K)
   ├─ Default-Open Failure Mode Injections (Stale DB, API Timeout)
   ├─ Reseller Bypass & Multi-Factory Policy Drift Probes
   └─ Audit Logging & Record Retention Verifiers
   │
   ▼
CONFIDENTIAL ASSURANCE REPORT
Screening Version: 42.8 | Detection: 99.8% | Workflow Bypass: PASS | Status: VERIFIED
```

## Governance & Safety Moat

- **Responsible Disclosure**: Challenge sequence details remain strictly within a vetted, secure environment to prevent adversary feedback.
- **Independent Certification**: Grants verified badges to providers, satisfying NIH/NSF research funding procurement requirements and biosecurity insurer criteria.

---

## 7-Day Payment Experiment
Conduct a simulated workflow-bypass audit against 2 mock gene synthesis order-routing API endpoints.
